Indication
Intraoperative Hypotension
1 clinical trial
1 product
1 drug
Clinical trial
Exploring the Use of Remimazolam (BYFAVO®) in Patients at High Risk for ERCP to Reduce Intraoperative Hypotension and Assess Safety and Efficacy: A Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2028-12-31
Product
RemimazolamDrug
placebo